Literature DB >> 25789733

CO2 angiography for peripheral arterial imaging: the good, bad, and ugly.

Anand Prasad1.   

Abstract

This article demonstrates that carbon dioxide (CO2) based angiography can be performed in patients at risk of acute kidney injury (AKI) with a resulting rate of AKI of ∼5%. The study also demonstrates a high rate of complications from CO2 angiography--ranging from pain to death. Future research will need to focus on clarifying the role of CO2 angiography given the safety profile noted in the literature.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25789733     DOI: 10.1002/ccd.25882

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  Evaluation of a novel 2D perfusion angiography technique independent of pump injections for assessment of interventional treatment of peripheral vascular disease.

Authors:  Jan B Hinrichs; Tim Murray; Muharrem Akin; Michael Lee; Micheal Ulrich Brehm; Mathias Wilhelmi; Frank K Wacker; Thomas Rodt
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-26       Impact factor: 2.357

2.  Combination of Carbon Dioxide Angiography and Outback® Elite for Revascularization of a Patient with Renal Insufficiency with Bilateral Femoropopliteal Chronic Total Occlusions.

Authors:  Yuhei Nojima; Shinsuke Nanto; Hidenori Adachi; Madoka Ihara; Tetsuya Kurimoto
Journal:  Case Rep Cardiol       Date:  2017-07-09

3.  Quiescent-Interval Single-Shot Magnetic Resonance Angiography May Outperform Carbon-Dioxide Digital Subtraction Angiography in Chronic Lower Extremity Peripheral Arterial Disease.

Authors:  Judit Csőre; Ferenc Imre Suhai; Marcell Gyánó; Ákos András Pataki; Georgina Juhász; Milán Vecsey-Nagy; Dániel Pál; Daniele Mariastefano Fontanini; Ákos Bérczi; Csaba Csobay-Novák
Journal:  J Clin Med       Date:  2022-08-01       Impact factor: 4.964

4.  Carbon dioxide contrast medium for endovascular treatment of ilio-femoral occlusive disease.

Authors:  Cynthia de Almeida Mendes; Alexandre de Arruda Martins; Marcelo Passos Teivelis; Sergio Kuzniec; Andrea Yasbek Monteiro Varella; Alexandre Fioranelli; Nelson Wolosker
Journal:  Clinics (Sao Paulo)       Date:  2015-10       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.